T-PA stimulates VEGF expression in endothelial cells via ERK2/p38 signaling pathways

Pharmazie

Volumn 69, Issue 1, 2014, Pages 70-75

  Duan, Pengfei ^a   Ni, Caifang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOVIRUS VECTOR; ALTEPLASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; INCUBATION TIME; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSACTIVATION; VIRAL GENE DELIVERY SYSTEM; VIRUS STRAIN;

ADENOVIRIDAE; BLOTTING, WESTERN; CELL LINE; ENDOTHELIAL CELLS; HUMANS; INDICATORS AND REAGENTS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893186760     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.3655     Document Type: Article

References (26)

1. Banerjee S, Dowsett M, Ashworth A, Martin LA (2007) Mechanisms of disease: angiogenesis and the management of breast cancer. Nat Clin Pract Oncol 4:536-550. (Pubitemid 47351464)
2. Benezra D (1978) Neovascularization ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Opthalmol 86: 455-461.
3. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, Van deWater L (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176: 1375-1379.
4. Chiang IT, Liu YC, Wang WH, Hsu FT, Chen HW, Lin WJ, Chang WY, Hwang JJ (2012) Sorafenib inhibits TPA-induced MMP-9 and VEGF expression viasuppression of ERK/NF-B pathway in hepatocellular carcinoma cells. In Vivo 26: 671-681.
5. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. (Pubitemid 17064313)
6. ConnollyDT, HeuvelmanDM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 84: 1470-1478. (Pubitemid 19272234)
7. Corvol P (2008) VEGF, anti-VEGF and diseases. Bull Acad Natl Med 192: 289-300.
8. Davis RJ (1993) The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556. (Pubitemid 23206581)
9. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188. (Pubitemid 24294584)
10. Ferrara N (2001) Role of vascular endothelial growth factor inregulation of physiological angiogenesis.AmJ Physiol Cell Physiol 280: C1358-1366.
11. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934.
12. Form DM, Auerbach R (1983) PGE2 and angiogenesis. Proc Soc Exp Biol Med 172: 214-218.
13. Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Dhiarugi V, Masisni E (2001) Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 3: 53-61. (Pubitemid 32201610)
14. Grothey A, Ellis LM. (2008) Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies. Cancer J 14: 170-177.
15. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW (1991) The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814.
16. Hsu JY, Wakelee HA (2009) Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy. BioDrugs 23: 289-304.
17. Jones MK, Itani RM, Wang H, Tomikawa M, Sarfeh IJ, Szabo S, (1999) Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury. Am J Physiol 276: G1345-1355. (Pubitemid 29323440)
18. LeungDW, Cachianes G, Kuang WJ, GoeddelDV, FerraraN(1989)Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
19. Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC (2000) Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 164: 820-825. (Pubitemid 30637640)
20. Mehrabi MR, Ekmekcioglu C, Stanek B, Thalhammer T, Tamaddon F, Pacher, R, Steiner GE, Wild T, Grimm M, Spieckermann PG, Mall G, Glogar HD (2001) Angiogenesis stimulation in explanted hearts from patients pretreated with intravenous prostaglandin E (1). J Heart Lung Transplant 20: 465-473. (Pubitemid 32297757)
21. Nancy CJ, BarryM(1994) PGE2: A mediator of corneal endothelial wound repair in vitro. Am J Physiol 266: C269-C275.
22. Ohki M, Ohki Y, Ishihara M, Nishida C, Tashiro Y, Akiyama H, Komiyama H, Lund LR, Nitta A, Yamada K, Zhu Z, Ogawa H, Yagita H, Okumura K, NakauchiH, Werb Z, Heissig B, HattoriK(2010)Tissue type plasminogen activator regulates myeloid-cell dependentneoangiogenesis during tissue regeneration. Blood 115: 4302-4312.
23. Rigas B, Goldman IS, Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122: 518-523. (Pubitemid 23352474)
24. Spisni E, Manica F, Tomasi V (1992) Involvement of prostanoids in the regulation of angiogenesis by polypeptide growth factors. Prostaglandins Leukotrienes Essent Fatty Acids. 47: 111-115.
25. Xu N, Lei Z, Li XL, Zhang J, Li C, Feng GQ, Li DN, Liu JY, Wei Q, Bian TT, Zou TY (2013) Clinical study of tumor angiogenesis and perfusion imaging usingmulti-slice spiral computed tomography for breast cancer. Asian Pac J Cancer Prev 14: 429-433.
26. YangVW, Shields JM, Hamilton SR, Spannhake EW, Hubbard WC, Hylind LM, Robinson CR, Giardiello FM (1998) Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res 58: 1750-1753. (Pubitemid 28215104)